Monte Rosa Therapeutics (GLUE) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Monte Rosa Therapeutics (GLUE).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 4.21M | - | 13M (-44.93%) | 23M (-72.70%) | 85M (+40.03%) | 61M (+557.81%) | 9.22M (+96.17%) | 4.70M (+343.40%) | 1.06M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 44M | - | 37M (+19.67%) | 31M (-4.78%) | 32M (-17.19%) | 39M (+40.73%) | 28M (-1.57%) | 28M (+3.81%) | 27M (-0.41%) | 27M (-4.13%) | 28M (-2.65%) | 29M (+8.67%) | 27M (+7.60%) | 25M (+16.54%) | 21M (+1.91%) | 21M (+16.85%) | 18M (-1.16%) | 18M (+19.91%) | 15M (+3.28%) | 15M (+57.93%) | 9.27M (-32.24%) | 14M (+150.09%) | 5.47M (+12.55%) | 4.86M | - |
Selling General And Administrative | 10M | - | 9.07M (+11.98%) | 8.10M (-6.90%) | 8.70M (-0.91%) | 8.78M (+8.00%) | 8.13M (-12.39%) | 9.28M (+3.23%) | 8.99M (+16.30%) | 7.73M (-10.74%) | 8.66M (+6.26%) | 8.15M (+8.67%) | 7.50M (-1.57%) | 7.62M (+8.55%) | 7.02M (+11.43%) | 6.30M (-1.41%) | 6.39M (+21.48%) | 5.26M (+10.74%) | 4.75M (+36.10%) | 3.49M (+56.50%) | 2.23M (-12.55%) | 2.55M (+180.22%) | 910K (+68.52%) | 540K | - |
Operating Expenses | 54M | - | 46M (+18.04%) | 39M (-5.23%) | 41M (-14.17%) | 48M (+33.30%) | 36M (-4.28%) | 37M (+3.69%) | 36M (+3.30%) | 35M (-5.71%) | 37M (-0.67%) | 37M (+8.64%) | 34M (+5.45%) | 32M (+14.56%) | 28M (+4.15%) | 27M (+12.06%) | 24M (+3.89%) | 23M (+17.72%) | 20M (+9.66%) | 18M (+57.57%) | 12M (-29.14%) | 16M (+153.99%) | 6.39M (+18.33%) | 5.40M | - |
Depreciation And Amortization | 2.03M | - | 2.10M (-1.41%) | 2.13M (+3.90%) | 2.05M (-0.49%) | 2.06M (-1.90%) | 2.10M (+1.94%) | 2.06M (+8.42%) | 1.90M (+2.70%) | 1.85M (+1.09%) | 1.83M (+31.65%) | 1.39M (+20.87%) | 1.15M (+7.48%) | 1.07M (+3.88%) | 1.03M (+15.73%) | 890K (+18.67%) | 750K (-12.79%) | 860K (+43.33%) | 600K (+50.00%) | 400K (+48.15%) | 270K (-50.00%) | 540K | - | - | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -50.03M | - | -32.97M (+112.03%) | -15.55M | 44M (+238.77%) | 13M | -26.53M (-18.72%) | -32.64M (-6.61%) | -34.95M (+0.26%) | -34.86M (-5.71%) | -36.97M (-0.67%) | -37.22M (+8.64%) | -34.26M (+5.45%) | -32.49M (+14.56%) | -28.36M (+4.15%) | -27.23M (+12.06%) | -24.30M (+3.89%) | -23.39M (+17.72%) | -19.87M (+9.66%) | -18.12M (+57.57%) | -11.50M (-29.14%) | -16.23M (+153.99%) | -6.39M (+18.33%) | -5.40M | - |
Ebit | -50.03M (+29.61%) | -38.60M (+17.08%) | -32.97M (+112.03%) | -15.55M | 44M (+238.77%) | 13M | -26.53M (-18.72%) | -32.64M (-6.61%) | -34.95M (+0.26%) | -34.86M (-5.71%) | -36.97M (-0.67%) | -37.22M (+8.64%) | -34.26M (+5.45%) | -32.49M (+14.56%) | -28.36M (+4.15%) | -27.23M (+12.06%) | -24.30M (+3.89%) | -23.39M (+17.72%) | -19.87M (+9.66%) | -18.12M (+57.57%) | -11.50M (-3.60%) | -11.93M (+86.70%) | -6.39M (+18.33%) | -5.40M (+25.58%) | -4.30M |
EBITDA | -48.00M (+24.35%) | -38.60M (+25.00%) | -30.88M (+129.93%) | -13.43M | 46M (+205.77%) | 15M | -24.42M (-20.14%) | -30.58M (-7.47%) | -33.05M (+0.09%) | -33.02M (-6.01%) | -35.13M (-1.95%) | -35.83M (+8.22%) | -33.11M (+5.38%) | -31.42M (+14.97%) | -27.33M (+3.76%) | -26.34M (+11.85%) | -23.55M (+4.53%) | -22.53M (+16.92%) | -19.27M (+8.75%) | -17.72M (+57.79%) | -11.23M (-0.18%) | -11.25M (+71.49%) | -6.56M (+22.39%) | -5.36M (+24.65%) | -4.30M |
Other Income / Expenses | |||||||||||||||||||||||||
Other Non Operating Income | 5.58M | - | 2.72M (-39.01%) | 4.46M (+21.53%) | 3.67M (-66.58%) | 11M (+300.73%) | 2.74M (+6.20%) | 2.58M (-15.69%) | 3.06M (-63.13%) | 8.30M (+268.89%) | 2.25M (+0.90%) | 2.23M (+0.45%) | 2.22M (-42.78%) | 3.88M (+273.08%) | 1.04M (+36.84%) | 760K (+105.41%) | 370K | -1.08M | 30K | -280.00K (-63.64%) | -770.00K (-90.22%) | -7.87M (+4529.41%) | -170.00K | 30K | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | -44.45M | - | -30.26M (+172.61%) | -11.10M | 48M (+205.83%) | 16M | -23.79M (-20.86%) | -30.06M (-5.71%) | -31.88M (-4.18%) | -33.27M (-4.15%) | -34.71M (-0.80%) | -34.99M (+9.21%) | -32.04M (-41.44%) | -54.71M (+100.26%) | -27.32M (+3.21%) | -26.47M | - | - | - | - | - | - | - | - | - |
Income Tax Expense | 50K | - | -3.18M | 1.20M (+46.34%) | 820K (-62.04%) | 2.16M (+2985.71%) | 70K (-72.00%) | 250K (+212.50%) | 80K | -20.00K | 170K (-10.53%) | 190K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -44.50M (+15.28%) | -38.60M (+42.54%) | -27.08M (+120.34%) | -12.29M | 47M (+248.88%) | 13M | -23.86M (-21.28%) | -30.31M (-5.19%) | -31.97M (-3.85%) | -33.25M (-4.67%) | -34.88M (-0.85%) | -35.18M (+9.80%) | -32.04M (+4.09%) | -30.78M (+12.66%) | -27.32M (+3.21%) | -26.47M (+10.61%) | -23.93M (+2.09%) | -23.44M (+18.15%) | -19.84M (+7.83%) | -18.40M (+49.84%) | -12.28M (-37.51%) | -19.65M (+199.54%) | -6.56M (+22.39%) | -5.36M (+24.65%) | -4.30M |
Net Income | -44.50M (+15.28%) | -38.60M (+42.54%) | -27.08M (+120.34%) | -12.29M | 47M (+248.88%) | 13M | -23.86M (-21.28%) | -30.31M (-5.19%) | -31.97M (-3.85%) | -33.25M (-4.67%) | -34.88M (-0.85%) | -35.18M (+9.80%) | -32.04M (+4.09%) | -30.78M (+12.66%) | -27.32M (+3.21%) | -26.47M (+10.61%) | -23.93M (+2.09%) | -23.44M (+18.15%) | -19.84M (+7.83%) | -18.40M (+49.84%) | -12.28M (-37.51%) | -19.65M (+199.54%) | -6.56M (+22.39%) | -5.36M (+24.65%) | -4.30M |
Comprehensive Income Net Of Tax | -45.42M | - | -26.95M (+118.40%) | -12.34M | 47M | -73.33M (+211.91%) | -23.51M (-22.38%) | -30.29M (-5.17%) | -31.94M (-76.57%) | -136.32M (+292.85%) | -34.70M (-2.03%) | -35.42M (+11.81%) | -31.68M (-70.73%) | -108.23M (+294.14%) | -27.46M (+2.50%) | -26.79M (+11.44%) | -24.04M (-67.91%) | -74.92M (+267.80%) | -20.37M (+7.78%) | -18.90M (+55.68%) | -12.14M (-67.13%) | -36.93M (+462.96%) | -6.56M (+22.39%) | -5.36M | - |